Ketanserin in the treatment of progressive systemic sclerosis

G. F. Altomare, P. D. Pigatto, M. M. Polenghi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations. The authors have treated 10 PSS patients with ketanserin, a selective antagonist of the S2 serotonin receptors, which are found in small vessels and platelets. Their results show that ketanserin represents an efficacious and very well tolerated therapy for treatment of the initial vascular symptoms of PSS.

Original languageEnglish
Pages (from-to)583-586
Number of pages4
JournalAngiology
Volume39
Issue number7 I
Publication statusPublished - 1988

Fingerprint

Diffuse Scleroderma
Ketanserin
Serotonin 5-HT2 Receptors
Blood Vessels
Serotonin
Therapeutics
Blood Platelets

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ketanserin in the treatment of progressive systemic sclerosis. / Altomare, G. F.; Pigatto, P. D.; Polenghi, M. M.

In: Angiology, Vol. 39, No. 7 I, 1988, p. 583-586.

Research output: Contribution to journalArticle

@article{6c8132b58c4d42bbbdb66df82c4e3748,
title = "Ketanserin in the treatment of progressive systemic sclerosis",
abstract = "Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations. The authors have treated 10 PSS patients with ketanserin, a selective antagonist of the S2 serotonin receptors, which are found in small vessels and platelets. Their results show that ketanserin represents an efficacious and very well tolerated therapy for treatment of the initial vascular symptoms of PSS.",
author = "Altomare, {G. F.} and Pigatto, {P. D.} and Polenghi, {M. M.}",
year = "1988",
language = "English",
volume = "39",
pages = "583--586",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "7 I",

}

TY - JOUR

T1 - Ketanserin in the treatment of progressive systemic sclerosis

AU - Altomare, G. F.

AU - Pigatto, P. D.

AU - Polenghi, M. M.

PY - 1988

Y1 - 1988

N2 - Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations. The authors have treated 10 PSS patients with ketanserin, a selective antagonist of the S2 serotonin receptors, which are found in small vessels and platelets. Their results show that ketanserin represents an efficacious and very well tolerated therapy for treatment of the initial vascular symptoms of PSS.

AB - Now progressive systemic sclerosis (PSS) is considered a disease of small vessels with which many immunologic alterations are associated. The presence in the blood of large amounts of serotonin can be considered a very important aggravating factor able to cause the sclerodermic alterations. The authors have treated 10 PSS patients with ketanserin, a selective antagonist of the S2 serotonin receptors, which are found in small vessels and platelets. Their results show that ketanserin represents an efficacious and very well tolerated therapy for treatment of the initial vascular symptoms of PSS.

UR - http://www.scopus.com/inward/record.url?scp=0023740452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023740452&partnerID=8YFLogxK

M3 - Article

C2 - 3408023

AN - SCOPUS:0023740452

VL - 39

SP - 583

EP - 586

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 7 I

ER -